• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

Novartis AG ADR NVS

Last Price$72.20Day Change (%)-1.08%
Open Price$72.31Day Change ($)-0.79
Day Range71.55–72.5852-Week Range71.55–106.84

As of Thu 2/11/2016 6:28:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Panel Recommends FDA Approval of Remicade Knockoff

    Panel Recommends FDA Approval of Remicade Knockoff

  2. Osteoarthritis Therapeutics Pipeline Review, H2 2015 - Research and Markets

    Osteoarthritis Therapeutics Pipeline Review, H2 2015 - Research and Markets

  3. Panel Recommends FDA Approval of Remicade Knockoff

    Panel Recommends FDA Approval of Remicade Knockoff

  4. Novartis Profit Dives 57% on Eye-Care Woes --2nd Update

    Novartis Profit Dives 57% on Eye-Care Woes --2nd Update

  5. Novartis 4Q Net Profit Falls 57% as Eye-Care Unit Drags on Results

    Novartis 4Q Net Profit Falls 57% as Eye-Care Unit Drags on Results

  6. Novartis Net Profit Falls 57%

    Novartis Net Profit Falls 57%

  7. Incyte Announces Decision to Discontinue JANUS Studies of Ruxolitinib plus Capecitabine in Patients with Advanced or Metastatic Pancreatic Cancer

    Incyte Announces Decision to Discontinue JANUS Studies of Ruxolitinib plus Capecitabine in Patients with Advanced or Metastatic Pancreatic Cancer

  8. Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Recent Period Progress

    Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Recent Period Progress

  9. Publicis Groupe: 2015 Annual Results

    Publicis Groupe: 2015 Annual Results

  10. Dr. Reddy’s Q3 and 9M FY16 Financial Results

    Dr. Reddy’s Q3 and 9M FY16 Financial Results

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.